While patients in Novo trials don't need to take any action, the company recommends patients "remain vigilant and report to ...

With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries are calling for ...

Last year, Johnson & Johnson arrived late to the party with Imaavy as the third FcRn blocker approved since 2021 to treat ...

Madrigal Pharmaceuticals has installed a 20-foot-tall, 41-foot-wide inflatable liver in a Philadelphia park to mark Global ...

Three short films created through an Eli Lilly-sponsored initiative are premiering at the Tribeca Festival, furthering the ...

In the air-conditioned haven of the Hilton just downriver from the American Diabetes Association’s 2026 Scientific Sessions in New Orleans, Mike Doustdar spoke with a quiet confidence and a smile as ...

Teva Pharmaceuticals plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes ...

Almost two-thirds of Americans who have asked artificial intelligence tools for medical advice acted on the guidance without ...

Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the ...

Gilead’s lenacapavir has been on the market since 2022, when it was approved in the U.S. as Sunlenca for twice-yearly ...

It’s a sign of the times that this year’s American Diabetes Association (ADA) Scientific Sessions meeting in New Orleans ...

The LinkedIn activities of AstraZeneca employees have yet again landed the drugmaker in hot water, with the U.K. marketing ...